This randomised control trial is sponsored by the British Heart Foundation is assessing the safety and efficacy of transdermal glyceryl trinitrate (GTN) is beneficial to patients.



Participating Ambulance Services:



East of England Ambulance Service
East Midlands Ambulance Service
London Ambulance Service
North West Ambulance Service
West Midlands Ambulance Service
Yorkshire Ambulance Service


For more information, visit the trial website: http://right-2.ac.uk/


If you’d like to work with ambulance services from across the UK to develop a similar project contact us.